Sesen Bio, Inc.
Sesen Bio, Inc. (SESN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
sesn · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Sesen Bio, Inc. (SESN) measures how much investors pay for each dollar of the company's trailing earnings. SESN's current PE ratio of 0.84x is calculated by dividing its stock price of $0.63 by its TTM earnings per share of $0.74. −52.0% discount vs 5Y avg 1.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2011 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Sesen Bio, Inc.You SESN | $128M | 0.84x | — | $0.74 |
 aTyr Pharma, Inc. ATYR | $43M | N/A | — | -$0.80 |
 Decibel Therapeutics, Inc. DBTX | $123M | N/A | — | -$2.52 |
 Graybug Vision, Inc. GRAY | $121M | N/A | — | -$0.00 |
 Kinnate Biopharma Inc. KNTE | $125M | N/A | — | -$2.42 |
 NGM Biopharmaceuticals, Inc. NGM | $129M | N/A | — | -$1.73 |
 Pardes Biosciences, Inc. PRDS | $135M | N/A | — | -$1.61 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-1.46 | — | |
2022-12-31 FY2022 | — | $-1.99 | — | |
2021-12-31 FY2021 | — | $-0.04 | — | |
2020-12-31 FY2020 | — | $-3.79 | — | |
2019-12-31 FY2019 | — | $-39.40 | — | |
2018-12-31 FY2018 | — | $-11.17 | — | |
2017-12-31 FY2017 | — | $-22.24 | — | |
2016-12-31 FY2016 | 1.76x | $1.79 | — | |
2015-12-31 FY2015 | — | $-35.23 | — | |
2014-12-31 FY2014 | — | $-46.65 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Sesen Bio, Inc. (SESN) measures how much investors pay for each dollar of the company's trailing earnings. SESN's current PE ratio of 0.84x is calculated by dividing its stock price of $0.63 by its TTM earnings per share of $0.74.
Frequently asked questions
SESN pe ratio · 6 questionsSESN's current PE ratio is 0.84x as of 2026-06-09, based on a stock price of $0.63 and TTM EPS of $0.74. Data sourced from Financial Modeling Prep via SESN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Sesen Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09